FWM
EXAS

Filbrandt Wealth Management’s Exact Sciences EXAS Stock Holding History

Filbrandt Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30
Closed -$2K – 401
2020
Q1 		$2K Buy
+30
New +$2.44K ﹤0.01% 177

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Filbrandt Wealth Management's EXAS Position: Q2 2020 in Review

Filbrandt Wealth Management sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 30 shares — an estimated $2K sold.

Filbrandt Wealth Management first reported a position in EXAS in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Filbrandt Wealth Management reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Filbrandt Wealth Management sold 30 Exact Sciences shares in Q2 2020, an estimated $2K.
  • Filbrandt Wealth Management first reported a position in Exact Sciences in Q1 2020 and held it in 1 quarter.
  • Filbrandt Wealth Management's Exact Sciences position peaked at $2K in Q1 2020.
  • 513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Filbrandt Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.